Congresswoman Vicky Hartzler (R-MO) has introduced the Protecting Higher Education from the Chinese Communist Party Act, which would ban "individuals serving in the National Congress of the Chinese Communist Party and their family members from receiving student or research visas."

China and New Zealand recently announced that an upgraded set of bilateral trade rules would come into force in April. The new rules would facilitate trade in goods and services and could boost bilateral trade flows.

Today the Office of the United States Trade Representative (USTR) issued its 20th report on China's compliance with "commitments made in connection with its accession to the World Trade Organization (WTO), including both multilateral commitments and any bilateral commitments made to the United States."

Yesterday, the U.S. Patent and Trademark Office (USPTO) released a study on “Patenting Activity among 5G Technology Developers.” One key takeaway is that "[t]he findings of the report call into question claims that any single firm or country is 'winning' the 5G technology race."

Recently, an advisory committee of the U.S. Food and Drug Administration voted in favor of requiring additional trial data in order for a China-trialed medicine to obtain FDA approval. This decision could have major implications for future regulatory approval applications for medicines developed in China. The FDA'

China's Ministry of Industry and Information Technology recently published a revised version of a proposed regulation governing data security in industrial and information sectors. The change, to some extent, broadens the scope of the regulation. The agency previously published the first draft last September.

Two Republican Senators and one Republican Congresswoman have introduced legislation that they say would "direct the U.S. Securities and Exchange Commission (SEC) to require companies listed on U.S. exchanges to identify whether a Chinese Communist Party (CCP) organization is present in the firm’s operations."